1. Raynaud's disease, Raynaud's phenomenon, and serotonin;Halpern;Angiology,1960
2. Treatment of Raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5-HT2) receptor;Seibold;Arthritis Rheum,1984
3. Fluoxetine: clinical pharmacology and physiologic disposition;Lemberger;J Clin Psychiatry,1985
4. Fluoxetine and the bleeding time;Humphries;Arch Pathol Lab Med,1990
5. Case of fluoxetine-induced remission of Raynaud's phenomenon—a case report;Bolte;Angiology,1993